- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- monomer
- Ligands
- 1 x JTZ: (2S)-1-[(1-methylethyl)amino]-3-(2-prop-2-en-1-ylphenoxy)propan-2-ol(Non-covalent)
- 1 x CLR: CHOLESTEROL(Non-covalent)
- 7 x OLB: (2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
OLB.3: 6 residues within 4Å:- Chain A: I.79, A.83, K.84
- Ligands: OLC.15, OLC.16, OLA.18
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:I.79
OLB.4: 3 residues within 4Å:- Chain A: F.113, F.125, W.129
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:F.113, A:W.129
OLB.5: 7 residues within 4Å:- Chain A: W.146, V.150, V.153, D.154, F.157, L.168, L.169
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:W.146
- Water bridges: A:S.167, A:L.168
OLB.6: 6 residues within 4Å:- Chain A: K.425, G.428, I.429, G.432, T.433
- Ligands: OLA.20
No protein-ligand interaction detected (PLIP)OLB.7: 2 residues within 4Å:- Chain A: L.492
- Ligands: OLC.16
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:L.492
OLB.8: 6 residues within 4Å:- Chain A: L.77, C.479, R.485, F.488, L.492, L.494
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:F.488, A:L.492
OLB.10: 2 residues within 4Å:- Chain A: S.65, L.119
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:L.119
- 3 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
OLC.9: 5 residues within 4Å:- Chain A: W.146, I.177, M.180, V.181, V.184
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:W.146, A:W.146, A:I.177, A:M.180, A:V.181, A:V.184
OLC.15: 6 residues within 4Å:- Chain A: I.79, T.97, C.101, L.104
- Ligands: CLR.2, OLB.3
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:L.104
- Hydrogen bonds: A:Y.94, A:Y.94
OLC.16: 6 residues within 4Å:- Chain A: F.73, L.77, L.491
- Ligands: OLB.3, OLB.7, OLA.18
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:F.73, A:F.73, A:F.73, A:F.73, A:L.77
- 4 x SO4: SULFATE ION(Non-functional Binders)
SO4.11: 7 residues within 4Å:- Chain A: T.90, V.91, T.92, R.155, Y.165, Q.166, S.167
7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:T.90, A:V.91, A:T.92, A:T.92, A:Y.165, A:S.167
- Salt bridges: A:R.155
SO4.12: 4 residues within 4Å:- Chain A: F.416, K.422, K.425, R.480
3 PLIP interactions:3 interactions with chain A- Salt bridges: A:K.422, A:K.425, A:R.480
SO4.13: 5 residues within 4Å:- Chain A: F.367, T.368, N.369, S.370, N.385
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:F.367, A:N.369, A:S.370, A:N.385
SO4.14: 4 residues within 4Å:- Chain A: T.395, P.396, N.397, R.398
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:T.395, A:N.397, A:N.397, A:R.398
- 4 x OLA: OLEIC ACID(Non-covalent)
OLA.17: 6 residues within 4Å:- Chain A: M.60, M.64, I.118, I.461, W.465, I.466
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:I.118, A:I.461, A:W.465, A:W.465, A:I.466
OLA.18: 3 residues within 4Å:- Chain A: T.80
- Ligands: OLB.3, OLC.16
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:T.80
OLA.19: 4 residues within 4Å:- Chain A: Y.156, F.241, V.242, R.245
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:Y.156, A:Y.156, A:F.241, A:V.242
- Hydrogen bonds: A:F.241
- Salt bridges: A:R.245
OLA.20: 7 residues within 4Å:- Chain A: V.240, S.244, F.247, G.428, G.432, T.435
- Ligands: OLB.6
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:F.247, A:T.435
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ishchenko, A. et al., Toward G protein-coupled receptor structure-based drug design using X-ray lasers. Iucrj (2019)
- Release Date
- 2019-11-13
- Peptides
- Fusion protein of Beta-2 adrenergic receptor and T4 Lysozyme: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- monomer
- Ligands
- 1 x JTZ: (2S)-1-[(1-methylethyl)amino]-3-(2-prop-2-en-1-ylphenoxy)propan-2-ol(Non-covalent)
- 1 x CLR: CHOLESTEROL(Non-covalent)
- 7 x OLB: (2S)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
- 3 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)
- 4 x SO4: SULFATE ION(Non-functional Binders)
- 4 x OLA: OLEIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ishchenko, A. et al., Toward G protein-coupled receptor structure-based drug design using X-ray lasers. Iucrj (2019)
- Release Date
- 2019-11-13
- Peptides
- Fusion protein of Beta-2 adrenergic receptor and T4 Lysozyme: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.